Literature DB >> 20359476

Genetic evidence that SOST inhibits WNT signaling in the limb.

Nicole M Collette1, Damian C Genetos, Deepa Murugesh, Richard M Harland, Gabriela G Loots.   

Abstract

SOST is a negative regulator of bone formation, and mutations in human SOST are responsible for sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects, suggesting that SOST may function embryonically. Here we report that overexpression of SOST leads to loss of posterior structures of the zeugopod and autopod by perturbing anterior-posterior and proximal-distal signaling centers in the developing limb. Mutant mice that overexpress SOST in combination with Grem1 and Lrp6 mutations display more severe limb defects than single mutants alone, while Sost(-/-) significantly rescues the Lrp6(-/-) skeletal phenotype, signifying that SOST gain-of-function impairs limb patterning by inhibiting the WNT signaling through LRP5/6. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359476      PMCID: PMC2896299          DOI: 10.1016/j.ydbio.2010.03.021

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  50 in total

1.  Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge.

Authors:  Jeffery R Barrow; Kirk R Thomas; Oreda Boussadia-Zahui; Robert Moore; Rolf Kemler; Mario R Capecchi; Andrew P McMahon
Journal:  Genes Dev       Date:  2003-02-01       Impact factor: 11.361

2.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

4.  Dosage-dependent hedgehog signals integrated with Wnt/beta-catenin signaling regulate external genitalia formation as an appendicular program.

Authors:  Shinichi Miyagawa; Anne Moon; Ryuma Haraguchi; Chie Inoue; Masayo Harada; Chiaki Nakahara; Kentaro Suzuki; Daisuke Matsumaru; Takehito Kaneko; Isao Matsuo; Lei Yang; Makoto M Taketo; Taisen Iguchi; Sylvia M Evans; Gen Yamada
Journal:  Development       Date:  2009-12       Impact factor: 6.868

5.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

6.  BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.

Authors:  Nobuhiro Kamiya; Ling Ye; Tatsuya Kobayashi; Yoshiyuki Mochida; Mitsuo Yamauchi; Henry M Kronenberg; Jian Q Feng; Yuji Mishina
Journal:  Development       Date:  2008-10-16       Impact factor: 6.868

Review 7.  The role of Dickkopf-1 in bone development, homeostasis, and disease.

Authors:  Joseph J Pinzone; Brett M Hall; Nanda K Thudi; Martin Vonau; Ya-Wei Qiang; Thomas J Rosol; John D Shaughnessy
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

8.  Multiple roles of mesenchymal beta-catenin during murine limb patterning.

Authors:  Theo P Hill; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Development       Date:  2006-02-22       Impact factor: 6.868

9.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

10.  Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity.

Authors:  Ying Litingtung; Randall D Dahn; Yina Li; John F Fallon; Chin Chiang
Journal:  Nature       Date:  2002-08-18       Impact factor: 49.962

View more
  20 in total

1.  [SOST knockdown promotes differentiation of osteoblasts MG63 and mesenchymal stem cells C3H10 in an in vitro model of bone metastasis of breast cancer].

Authors:  Jia-Yi Huang; Dan Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 2.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

3.  Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.

Authors:  Nicole M Collette; Cristal S Yee; Nicholas R Hum; Deepa K Murugesh; Blaine A Christiansen; LiQin Xie; Aris N Economides; Jennifer O Manilay; Alexander G Robling; Gabriela G Loots
Journal:  Bone       Date:  2016-04-19       Impact factor: 4.398

Review 4.  Sclerostin expression and functions beyond the osteocyte.

Authors:  Megan M Weivoda; Stephanie J Youssef; Merry Jo Oursler
Journal:  Bone       Date:  2016-11-23       Impact factor: 4.398

5.  Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo.

Authors:  Kyu Sang Joeng; Cassie A Schumacher; Cassandra R Zylstra-Diegel; Fanxin Long; Bart O Williams
Journal:  Dev Biol       Date:  2011-09-05       Impact factor: 3.582

Review 6.  The regulation of valvular and vascular sclerosis by osteogenic morphogens.

Authors:  Kristina I Boström; Nalini M Rajamannan; Dwight A Towler
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

Review 7.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

8.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass.

Authors:  Nicole M Collette; Damian C Genetos; Aris N Economides; LiQin Xie; Mohammad Shahnazari; Wei Yao; Nancy E Lane; Richard M Harland; Gabriela G Loots
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-10       Impact factor: 11.205

Review 9.  Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.

Authors:  Rajiv Kumar; Volker Vallon
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

Review 10.  Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.

Authors:  Megan M Weivoda; Merry Jo Oursler
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.